We have studied the relationships among SWISS-PROT, TrEMBL, and GenBank with two goals. First is to determine whether users can reliably identify those proteins in SWISS-PROT whose functions were determined experimentally, as opposed to proteins whose functions were predicted computationally. If this information was present in reasonable quantities, it would allow researchers to decrease the propagation of incorrect function predictions during sequence annotation, and to assemble training sets for developing the next generation of sequence-analysis algorithms. Second is to assess the consistency between translated GenBank sequences and sequences in SWISS-PROT and TrEMBL. Results: (1) Contrary to claims by the SWISS-PROT authors, we conclude that SWISS-PROT does not identify a significant number of experimentally characterized proteins. (2) SWISS-PROT is more incomplete than we expected in that version 38.0 from July 1999 lacks many proteins from the full genomes of important organisms that were sequenced years earlier. (3) Even if we combine SWISS-PROT and TrEMBL, some sequences from the full genomes are missing from the combined dataset. (4) In many cases, translated GenBank genes do not exactly match the corresponding SWISS-PROT sequences, for reasons that include missing or removed methionines, differing translation start positions, individual amino-acid differences, and inclusion of sequence data from multiple sequencing projects. For example, results show that for Escherichia coli, 80.6% of the proteins in the GenBank entry for the complete genome have identical sequence matches with SWISS-PROT/TrEMBL sequences, 13.4% have exact substring matches, and matches for 4.1% can be found using BLAST search; the remaining 2.0% of E.coli protein sequences (most of which are ORFs) have no clear matches to SWISS-PROT/TrEMBL. Although many of these differences can be explained by the complexity of the DB, and by the curation processes used to
INTRODUCTION
Molecular Biology Databases (MBDs), with their rapidly expanding contents, are indispensible tools in the quest to better understand biological systems. However, MBDs are large and complex artifacts. Many MBDs integrate data from multiple sources, and transform those data using computer programs and manual annotation procedures that are complicated, are difficult to reproduce, and that change over time. These DBs are so complex that a full understanding of their properties (as distinct from the properties of the biological systems that the DBs model) requires empirical study. Indeed, one outcome of this work was to give the authors of this article, and presumably the reader, a greater appreciation of the complexities involved in producing SWISS-PROT.
Such studies can tell us several things, such as: (a) whether a given MBD conforms to properties advertized by its developers; (b) whether a given MBD conforms to properties that one would think to be obvious; (c) whether an MBD is internally consistent, or is consistent with respect to other data sources; and (d) what are specific aggregate properties of an MBD, such as its completeness, error rate, update rate, and species distribution. We believe such studies constitute a new subfield of bioinformatics analysis that we call database verification.
Database (DB) users who misunderstand certain properties of MBDs are in danger of misinterpreting computational experiments that they perform on those MBDs. For example, a bioinformatician who extracted all Escherichia coli sequences from SWISS-PROT with the intent of analyzing the full proteome of the K-12 strain of E.coli would be working with a dataset that lacks many K-12 proteins (those that have not yet entered SWISS-PROT, but that reside in TrEMBL), and that includes proteins from strains other than K-12. A different bioinformatician who extracted E.coli K-12 proteins from both SWISS-PROT and TrEMBL would still be missing 44 proteins from the complete genome of E.coli K-12 (Blattner et al., 1997) that are mysteriously absent from both SWISS-PROT and TrEMBL.
To investigate the consistency of sequence DBs, we extracted all protein-coding genes from several bacterial genomes in GenBank, translated the DNA sequences to protein sequences, and compared those protein sequences against all protein entries from the respective organism from both SWISS-PROT and TrEMBL. We call this work the correspondence study.
We also investigated the degree to which users of SWISS-PROT can reliably distinguish those proteins within the DB whose functions were experimentally determined from those whose functions were computationally predicted. We call this work the function metadata study. This work evolved from an editorial in Bioinformatics by Karp that discussed the risks due to propagation of incorrect annotation in sequence DB entries (Karp, 1999) . Researchers often find sequence similarities between unknown sequences of interest, and sequences in DBs such as SWISS-PROT, and copy the function of the SWISS-PROT sequence to the function of their sequence, on the assumption that the sequence similarity implies a shared function. However, if the annotation of the SWISS-PROT sequence was incorrect, the function copied to the unknown sequence will in all likelihood also be incorrect.
The editorial proposed that sequence DBs such as SWISS-PROT should include metadata that distinguishes proteins whose functions were established experimentally from those whose functions were predicted computationally using sequence-analysis techniques. Systematic metadata of this sort could be used during the sequence-analysis process to increase prediction quality by preferring hits to sequences whose functions were established experimentally, to decrease propagation of less reliable annotations. This metadata would also aid the bioinformatics community in assembling a sequenceanalysis benchmark of proteins whose functions are known with relatively high confidence.
In response to that editorial, Junker et al. (1999) described the systems by which information about functional characterization is encoded in the SWISS-PROT DB. We note that neither of these systems are documented at all in the SWISS-PROT User Manual (version 39.0, which was released well after the publication of Junker et al. (1999) ), so it is not clear how users of SWISS-PROT would know of their existence other than through the Junker article. The SWISS-PROT systems are in principle quite comprehensive, and record metadata about the method of characterization for the overall function of the protein, and for features of the protein, such as its subcellular location. We investigate the degree to which the system for recording the method of characterization of the overall protein function has been implemented in SWISS-PROT.
The correspondence study was motivated by our attempt to create links from proteins in our EcoCyc DB (Karp et al., 2000) to their corresponding entries in SWISS-PROT. SWISS-PROT is widely accepted as a high-quality resource for proteomic data. When we began that project, we expected that because E.coli is an important genome that was completed several years ago, SWISS-PROT would contain all proteins from the full genome sequence of E.coli. We also expected that the sequences for most of the proteins in EcoCyc (which were copied exactly from GenBank entry U00096 (Blattner et al., 1997) ) could be matched to sequences in SWISS-PROT by using an exact string comparison, on the assumption that the SWISS-PROT curators would have altered the sequences of few E.coli proteins. Since the SWISS-PROT staff provides a value-added service of curating these sequences, we did anticipate that we would have to use the BLAST program to match up a few remaining pairs of proteins, but that this work would be trivial. We learned that these expectations were false-it was not easy to identify all corresponding proteins between EcoCyc and SWISS-PROT/TrEMBL.
METHODS

Datasets
The correspondence study is based on the complete GenBank nucleotide sequence entries for E.coli (accession U00096; Blattner et al., 1997) , for Haemophilus (Hm.) influenzae (L42023; Fleischmann et al., 1995) , and for Helicobacter (Hb.) pylori (AE000511; Tomb et al., 1997) . We performed our own translation of the nucleotide sequences that code for proteins to obtain a complete set of unique protein sequences from those genomes. The resulting protein sequence database dataset is called P-GEN.
We employed version 38.0 (July 1999) of SWISS-PROT and of TrEMBL (Bairoch and Apweiler, 2000) . TrEMBL is a companion DB to SWISS-PROT, and is a repository for translated coding regions extracted from the GenBank/EMBL DB that have undergone some computational annotation, but that have not yet undergone the full manual annotation required for deposition into SWISS-PROT. We extracted all entries from both SWISS-PROT and TrEMBL in which the Organism Species (OS) line matched one of the three preceding organisms. We combined the SWISS-PROT and TrEMBL data into a single dataset, called P-SPT.
The Function Metadata Study is based on the Hm.influenzae, Hb.pylori, and M.jannaschii subsets of SWISS-PROT version 38.0. 
Algorithms
The correspondence study uses the following algorithm for comparing the protein sequences in the P-GEN and P-SPT datasets.
(1) Perform a pairwise exact string comparison between P-GEN and P-SPT to extract all identical sequence matches between the two datasets.
(2) For the remaining sequences from the P-GEN dataset, perform a pairwise exact substring comparison between the two datasets to find cases where either the P-GEN sequence is an exact substring of the P-SPT sequence or vice versa. To qualify as a match, the shorter sequence must cover at least 70% of the longer sequence.
(3) Finally, for the remaining P-GEN sequences that
have not yet been matched, we perform a bidirectional best-hit BLAST search (using NCBI standalone BLAST software, BLOSUM 62 matrix, unmasked) to locate nearly identical sequences from the P-SPT DB. To only find matches with very small differences, our cutoff for accepting a sequence match is set to the combination of E value smaller than 10 −20 , best High Scoring Pair (HSP) with more than 93% identity, and with the length of the best HSP accounting for at least 70% of each sequence. Table 1 summarizes the matches we found between the P-GEN and P-SPT datasets by using the methods described in Section 2.2. Note that we expect the number of proteins for a given species to be higher in P-SPT than in P-GEN because the former set of proteins can encompass multiple strains of the same species, whereas proteins of the latter set are from a single genome. The non-identical matches were analyzed further to discover patterns in the differences. All but three of the E.coli substring matches differ in the start position-the other three differ in the end position. About half (274/567) of the E.coli substring differences, about 60% (80/127) of the Hm.influenzae substring differences, and all but one of the Hb.pylori substring differences were due to missing or removed methionines at the start of the SWISS-PROT/TrEMBL sequences.
RESULTS
Correspondence study
Of the 293 E.coli substring matches not attributable to missing initial methionines, the GenBank sequence was longer in 264 cases, and the SWISS-PROT sequence was longer in 29 cases. Many of the differences for E.coli are due to the work of Rudd (2000), who has modified the translation start and stop points of many E.coli genes in SWISS-PROT based on both experimental observations reported in the literature, and on corrections made by his own inspection and computational analysis of the sequence. For Hm.influenzae, the GenBank sequence was longer in 39 of the 47 cases. Figure 1 shows the distribution of length differences for these E.coli and Hm.influenzae pairs, both in absolute numbers of amino acids and as a percentage of the longer sequence. Figure 2 shows the distribution of identity scores among the BLAST matches for all three organisms. Identity in this context is measured by dividing the number of identical amino acids in the aligned region by the total length of the GenBank sequence. Because we require an identity score of at least 93% for the aligned region, identities of less than 93% result largely from differences in sequence length, probably due to disagreement about where the gene begins.
At least for E.coli, we posit that a likely cause for the sequence differences in those pairs that were matched by the BLAST search is that many of the E.coli sequences in SWISS-PROT were derived from smaller sequenced regions of the E.coli genome that were completed before the full genome was finished in 1997. That is, before 1997 many laboratories had sequenced short regions of the E.coli genome. Those regions were submitted to GenBank, and then entered SWISS-PROT. We propose that some of the SWISS-PROT sequences for E.coli K-12 proteins were not derived from GenBank entry U00096. It is also possible that the sequences for SWISS-PROT K-12 proteins come from multiple substrains of the K-12 strain. This hypothesis is supported by our examination of the 16 E.coli pairs with <95% identity, which reveals that 13 of the SWISS-PROT entries have a sequencelast-modified date earlier than the release of the complete E.coli genome. For example, SWISS-PROT entry P27243 was derived from GenBank entry M95398 (1993), and SWISS-PROT entry P33593 was derived from GenBank entry X73143 (1993) . Some of these entries cite strains other than the K-12/MG1655 strain that was used for the complete genome entry. For example, SWISS-PROT entry P28242 includes a reference to strain K-12/W3110 in addition to the more recent reference to MG1655. Many other entries do not contain specific strain or substrain information.
In general, the sequence differences we found were listed as conflicts in the feature table for the SWISS-PROT entry, but those conflicts are linked only to the references from which the sequence was derived, and neither the reference description nor the feature description contains a link to the i.d. of the associated GenBank entry. This makes it difficult to determine computationally which GenBank entry we should be comparing with. A more sophisticated matching algorithm might parse all the conflict features, creating all possible variants of the protein sequence implied by the SWISS-PROT entry, and try to find one that matches exactly. We did not implement this.
The eight Hb.pylori sequences with <95% identity all came from TrEMBL, and had not yet been entered into SWISS-PROT.
Our analysis still leaves 85 unmatched E.coli GenBank proteins, 100 unmatched Hm.influenzae proteins, and 34 unmatched Hb.pylori proteins. Our requirement of 70% identity for substring and BLAST matches is probably overly stringent. Reducing the minimum identity requirement to 10%, but still requiring a substring match or bidirectional best-hit BLAST match with E-value <10 −20 matches up an additional 41 E.coli sequence pairs and 39 Hm.influenzae sequence pairs.
All but three of the remaining 44 E.coli proteins have no predicted functions: some have putative functions assigned to them, but most are hypothetical ORFs, presumably generated by gene-prediction algorithms. They show no particular length distribution (that is, they are not all short polypeptides), nor are these proteins present in the REM-TrEMBL DB (which contains proteins intentionally omitted from TrEMBL). Of the three proteins that had predicted functions, one is an interrupted gene, one contains an internal frame shift (so our gene-to-protein translation was erroneous), and in the third case, a single SWISS-PROT protein matches two very similar GenBank genes, and lists both in the annotation. We hypothesized that an explanation for the E.coli proteins missing from SWISS-PROT (but in TrEMBL) might be that prophage proteins were being intentionally excluded from SWISS-PROT. However, this explanation is not correct: although a substantial number of the missing proteins are prophage proteins, many more are not, and many other E.coli prophage proteins are included in SWISS-PROT.
We looked up the 61 remaining unmatched Hm.influenzae proteins in the SWISS-PROT Hm.influenzae index file; 14 are matched with SWISS-PROT sequences that our algorithm did not find (our BLAST match requirements were too stringent), and 22 are listed as having been deleted. In 11 cases, the same SWISS-PROT accession number is linked to two nearly identical genes. This leaves 14 Hm.influenzae proteins for which we do not have matches in SWISS-PROT version 38.0.
All the 34 unmatched Hb.pylori proteins are hypothetical ORFs, for which neither SWISS-PROT nor TrEMBL has entries.
Results of the function metadata study
The SWISS-PROT project is to be commended for designing a system for annotating the types of functional characterization that its DB entries have received. Yet, in practice, the implementation of such a system can be incomplete. Therefore, we decided to subject some statements in Junker et al. (1999) to further scrutiny.
We begin with two definitions. We call proteins whose functions have been characterized experimentally PEFs, for Proteins with Experimentally characterized Functions. We call proteins with computationally characterized functions PCFs.
Surprisingly, SWISS-PROT uses different schemes to indicate that a protein is a PEF versus a PCF. 'When biochemical experiments have been undertaken to characterize a protein, this is added to the Reference Position (RP) line of the entry. This is part of the reference block and describes what has been determined in that publication' (Junker et al., 1999) . For example, the following lines from the reference section within a SWISS-PROT entry specify in both cases that the function of the protein was derived from the reference with which the RP line is associated. Conversely, proteins whose functions were determined computationally are indicated using the DE line (Junker et al., 1999) :
Not all entries in SWISS-PROT are fully characterized. With the increasing amount of data coming from mega-sequencing projects you will find more and more proteins in SWISS-PROT without experimental characterization. These proteins can be identified through their standardized labeling of the DE line.
That standardized labeling inserts the words 'putative,' 'probable,' or 'hypothetical' in the description lines of protein entries. We call these words the 'computational labels' because all imply that the function was derived computationally. The labels 'putative' and 'probable' are used for proteins that have a computationally predicted function; the label 'hypothetical' is used for proteins whose existence has been predicted computationally, but for which no specific function can be predicted with sufficient confidence. Consider the following example description lines from SWISS-PROT entries: Of the 80 000 entries in SWISS-PROT 38.0, only 409 (0.5%) contain an RP line containing the word 'function' † . Thus, the number of PEFs defined in SWISS-PROT is miniscule, and the ability of SWISS-PROT to identify PEFs is extremely incomplete.
The identification of PCFs is also incomplete. Of the 80 000 entries in SWISS-PROT 38.0, 3,404 (4.3%) contain the labels 'PUTATIVE' or 'PROBABLE.' (Note that 72 entries contain the label 'POSSIBLE,' which is not documented in Junker et al. (1999) .) The label 'HYPOTHET-ICAL' (meaning that many proteins in SWISS-PROT have no predicted function) is contained in 11 895 (14.9%) entries. Therefore, a minority (19.2%) of SWISS-PROT entries contain computational labels, and most of those entries have no predicted function. Put another way, for only 4.8% of SWISS-PROT entries is a function assigned, and does the DB specify whether the protein is a PCF or a PEF. For the majority of SWISS-PROT entries the user cannot tell how its function was determined.
It is also worth noting that seven SWISS-PROT entries both contain an RP line containing the word 'function,' and contain a computational label in their DE line, which is inconsistent since these labelings are mutually † More specifically, 409 entries contain the word 'function' but not the phrases 'probable function' nor 'putative function,' which terms are found in some RP lines. The SWISS-PROT User Manual does not document the full set of terms to be found in RP lines, so must estimate its meaning. exclusive according to the definitions given by Junker et al. This inconsistency reflects the haphazard design of this metadata system, which: (1) encodes highly related information in two separate lines in the DB; and (2) intermixes these metadata keywords with other information in the respective lines. A better design would be to separate the function metadata into a single line that could also refer to the reference from which it was derived.
DISCUSSION
Our results indicate that significant differences exist among translated genes within GenBank and SWISS-PROT/TrEMBL. SWISS-PROT/TrEMBL do not contain entries for some open reading frames defined in GenBank microbial genome entries. Most, but not all, of the missing proteins had no predicted functions in the GenBank entries. Whether these proteins were intentionally omitted from SWISS-PROT because its curators believe the proteins are not expressed, or were unintentionally lost during the curation process, is unclear. It might be advantageous if SWISS-PROT specifically identified proteins that were originally reported in a sequenced genome but that were intentionally removed from SWISS-PROT for some specific reason.
For a significant number of the proteins that are not missing, SWISS-PROT/TrEMBL contain different translation-start points, have removed the starting methionine, and contain differences in sequence that are in some cases quite significant. We posit that these differences arise from several underlying causes. Some are due to the added value that the SWISS-PROT staff provides through its literature-based curation efforts. Other differences are due to computational analyses-the SWISS-PROT staff is clearly revising computational predictions made by the sequencing projects such as locations of the translationstart point (and presumably, intron/exon boundaries for higher organisms). What is surprising to us is the large number of changes being made by the SWISS-PROT staff.
Other differences arise because of differing philosophies among the DBs. Because the SWISS-PROT philosophy is to include only a single sequence for a given protein from a given organism, and because the SWISS-PROT curators apparently chose not to replace existing SWISS-PROT sequences with sequences from complete-genome projects, the SWISS-PROT entries for any given organism are a mosaic of sequences obtained from different laboratories and strains. GenBank, in contrast, contains a different entry for each nucleotide sequencing project, even when that means including 'duplicate' sequences of the 'same' gene obtained by different laboratories. Both approaches have their advantages and disadvantages: the GenBank approach allows the DB to accurately encode the complete genome of a given organism; the SWISS-PROT approach produces a DB of lesser redundancy, but that less accurately models individual strains. Another difference in philosophy concerns their update models: most GenBank entries are updated by their authors only, which has led to an accumulation of uncorrected errors in GenBank. In contrast, the SWISS-PROT staff attempts to correct errors in all DB entries.
The higher level of ongoing annotation within SWISS-PROT leads to many changes within the SWISS-PROT data. However, because the reasons for changes in SWISS-PROT entries are not recorded within the DB, it is very difficult for the user to understand the rationale for a given change, when the change was made, and by whom. For the user who wants to investigate which changes were made because of solid experimental information, which changes were made because the DB curators applied a different computational annotation program than the laboratory that sequenced the complete genome, and which changes happen to be mistakes, there is little recourse.
This situation is unfortunate because attribution of sources is such an integral part of the scientific tradition. As DBs begin to replace the traditional scientific literature, it would be unfortunate to lose this tradition. DBs such as SWISS-PROT do of course contain literature citations, but they tend to be at a coarse granularity that does not identify the sources of specific facts. In the EcoCyc project we have solved this problem to some degree by enhancing our underlying DB management system with the ability to associate literature citations or comments with individual data values in a fashion that does not interfere with the ability to query those data values (Karp and Paley, 1996) .
Users who want to perform systematic analyses of annotated genomes are advised that they will obtain different results depending on whether they obtain their protein sets from translated GenBank entries, or from SWISS-PROT/TrEMBL, and that they should not employ SWISS-PROT alone because even for the older genomes it is still quite incomplete (for example, 379 proteins from the complete genome of E.coli are still not in SWISS-PROT). That incompleteness does not consist simply in omitting all proteins without predicted functions-11.6% of SWISS-PROT entries are hypothetical proteins without predicted functions. The incompleteness of SWISS-PROT with respect to these genomes was surprising to us, particularly because all three organisms studied here have been selected by the SWISS-PROT curators as model organisms, and have been specifically targeted to be as complete as possible (Bairoch and Apweiler, 2000) .
The results of our Function Metadata Study show that although SWISS-PROT contains a mechanism for indicating which SWISS-PROT entries have had their functions determined experimentally versus computationally, the implementation of that mechanism is far from complete. Only 0.5% of SWISS-PROT entries are marked as PEFs. This situation conflicts with the description of the metadata system by the SWISS-PROT authors in the earlier quotations, which does not describe the system as a work in its infancy.
Unfortunately, our findings show that bioinformatics efforts to reduce the incidence of transitive annotation errors, or to assemble significant benchmarking sets of proteins for evaluation of automated sequence-analysis programs, will have to wait.
Ultimately, the intention of this article is less to criticize SWISS-PROT in particular than it is to inspire a new level of critical examination of all molecular-biology DBs. Despite the widespread use of MBDs, few previous studies have examined their properties in a systematic fashion. If we expect MBDs to continue to play a major role in molecular biology, and to receive increasing funding levels in the future, we must develop a culture of critical but constructive evaluation of these resources to drive continual improvements in their quality.
